Samer Al Hadidi/UT Southwestern Simmons Cancer Center's LinkedIn
Mar 20, 2026, 16:22
Welcoming Samer Al Hadidi to the Blood Cancers Team – UT Southwestern Simmons Cancer Center
UT Southwestern Simmons Cancer Center shared a post on LinkedIn:
”Please join us in welcoming Samer Al Hadidi, M.D., to our blood cancers team.
He specializes in hematology and oncology, with an emphasis on plasma cell disorders, including multiple myeloma and light chain amyloidosis, and cellular therapies, including CAR T-cell therapy and hematopoietic stem cell transplantation.
Dr. Al Hadidi is the Clinical Director of the Amyloidosis Program at UT Southwestern.
He also serves as Leader of the Fellows’ Plasma Cell Disorders Clinic.
He is nationally recognized as an expert in treating multiple myeloma and utilizing cellular therapies for plasma cell disorders.
Learn more about Dr. Al Hadidi.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026